Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance

Journal of Cardiovascular Magnetic Resonance

Volumn 16, Issue 1, 2014, Pages

  Pica, Silvia ^a,b   Sado, Daniel M ^a,c   Maestrini, Viviana ^a,d   Fontana, Marianna ^a   White, Steven K ^a,c   Treibel, Thomas ^a,c   Captur, Gabriella ^a,c   Anderson, Sarah ^a   Piechnik, Stefan K ^a,e   Robson, Matthew D ^a,e   Lachmann, Robin H ^f   Murphy, Elaine ^f   Mehta, Atul ^g   Hughes, Derralyn ^g   Kellman, Peter ^h   Elliott, Perry M ^a,c   Herrey, Anna S ^a,c   Moon, James C ^a,c  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^g ROYAL FREE HOSPITAL   (United Kingdom)

^h NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Cardiovascular magnetic resonance; Diastolic function; Fabry disease; Speckle tracking strain; T1 mapping

Indexed keywords

ADULT; AGED; CASE CONTROL STUDY; COMPLICATION; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; EARLY DIAGNOSIS; FABRY DISEASE; FEMALE; GENETIC PREDISPOSITION; GENETICS; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PATHOPHYSIOLOGY; PHENOTYPE; PREDICTIVE VALUE; PROSPECTIVE STUDY; REPRODUCIBILITY; TIME FACTOR; YOUNG ADULT;

ADULT; AGED; CASE-CONTROL STUDIES; DISEASE PROGRESSION; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY, DOPPLER; FABRY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 85003045289     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/s12968-014-0099-4     Document Type: Article

References (29)

1. O'Mahony, C, Elliott, P, Anderson-fabry disease and the heart. ProgCardiovasc Dis 52:4 (2010), 326–335 10.1016/j.pcad.2009.11.002.
2. Mehta, A, Clarke, JTR, Giugliani, R, Elliott, P, Linhart, A, Beck, M, Sunder-Plassmann, G, Natural course of fabry disease: changing pattern of causes of death in FOS – fabry outcome survey. J Med Genet 46:8 (2009), 548–552 PubMed PMID: 19473999 10.1136/jmg.2008.065904.
3. Hughes, DA, Elliott, PM, Shah, J, Zuckerman, J, Coghlan, G, Brookes, J, Mehta, AB, Effects of enzyme replacement therapy on the cardiomyopathy of anderson-fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa. Heart 94:2 (2008), 153–158 PubMed PMID: 17483124 10.1136/hrt.2006.104026.
4. Moon, JC, Sachdev, B, Elkington, AG, McKenna, WJ, Mehta, A, Pennell, DJ, Leed, PJ, Elliott, PM, Gadolinium enhanced cardiovascular magnetic resonance in anderson-fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 24 (2003), 2151–2155 PubMed PMID: 14643276 10.1016/j.ehj.2003.09.017.
5. Deegan, PB, Baehner, AF, Barba Romero, MA, Hughes, DA, Kampmann, C, Beck, M, Natural history of fabry disease in females in the fabry outcome survey. J Med Genet 43:4 (2006), 347–352 PubMed PMID: 16227523, PMCID 2563231 10.1136/jmg.2005.036327.
6. Taciane, A, Filippo, V, V De Souza, M, C Krug, B, V D Schwartz, I, Enzyme replacement therapy for fabry disease: a systematic review and meta-analysis. Genet Mol Biol 35:4(suppl) (2012), 947–954.
7. Banikazemi, M, Bultas, J, Waldek, S, Wilcox, WR, Whitley, CB, McDonald, M, Finkel, R, Packman, S, Bichet, DG, Warnock, DG, Desnick, RJ, Agalsidase-beta therapy for advanced fabry disease: a randomized trial. Ann Intern Med 146 (2007), 77–86 PubMed PMID: 17179052 10.7326/0003-4819-146-2-200701160-00148.
8. Moon, JC, Messroghli, DR, Kellman, P, Piechnik, SK, Robson, MD, Ugander, M, Gatehouse, PD, Arai, AE, Friedrich, MG, Neubauer, S, Schulz-Menger, J, Schelbert, EB, Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson, 15, 2013, 92 PubMed PMID: 24124732, PMCID 3854458 10.1186/1532-429X-15-92.
9. Dass, S, Suttie, JJ, Piechnik, SK, Ferreira, VM, Holloway, CJ, Banerjee, R, Mahmod, M, Cochlin, L, Karamitsos, TD, Robson, MD, Watkins, H, Neubauer, S, Myocardial tissue characterization using magnetic resonance noncontrast T1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging 5:6 (2012), 726–733 PubMed PMID: 23071146 10.1161/CIRCIMAGING.112.976738.
10. Sado DM, Maestrini V, Piechnik SK, Banypersad SM, White SK, Flett AS, Robson MD, Neubauer S, Ariti C, Arai A, Kellman P, Yamamura J, Schoennagel BP, Shah F, Davis B, Trompeter S, Walker M, Porter J, Moon JC. Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload.J Magn Reson Imaging. 2014; 10.1002/jmri.24727.,.
11. Ferreira, VM, Piechnik, SK, Dall'Armellina, E, Karamitsos, TD, Francis, JM, Ntusi, N, Holloway, C, Choudhury, RP, Kardos, A, Robson, MD, Friedrich, MG, Neubauer, S, T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging 6:10 (2013), 1048–1058 PubMed PMID: 24011774 10.1016/j.jcmg.2013.03.008.
12. 1mapping with cardiovascular MRI is highly sensitive for fabry disease independent of hypertrophy and sex. Circ Cardiovasc Imaging 6 (2013), 637–645 PubMed PMID: 23922004 10.1161/CIRCIMAGING.113.000482.
13. Sado, DM, White, SK, Piechnik, SK, Banypersad, SM, Treibel, T, Captur, G, Fontana, M, Maestrini, V, Flett, AS, Robson, MD, Lachmann, RH, Murphy, E, Mehta, A, Hughes, D, Neubauer, S, Elliott, PM, Moon, JC, Identification and assessment of anderson fabry disease by cardiovascular magnetic resonance non-contrast myocardial T1 mapping. Circ Cardiovascular Imaging 6:3 (2013), 392–398 PubMed PMID: 23564562 10.1161/CIRCIMAGING.112.000070.
14. Maceira, AM, Prasad, SK, Khan, M, Pennell, DJ, Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 8:3 (2006), 417–426 PubMed PMID: 16755827 10.1080/10976640600572889.
15. Kellman, P, Herzka, DA, Arai, AE, Michael Schacht, H, Influence of Off-resonance in myocardial T1-mapping using SSFP based MOLLI method. J Cardiovasc Magn Reson, 15, 2013, 63 PubMed PMID: 23875774, PMCID 3733653 10.1186/1532-429X-15-63.
16. Lee, JJ, Liu, S, Nacif, MS, Ugander, M, Han, J, Kawel, N, Sibley, CT, Kellman, P, Arai, AE, Bluemke, DA, Myocardial T1 and extracellular volume fraction mapping at 3 Tesla. J Cardiovasc Magn Reson 28 (2011), 13–75.
17. Messroghli, DR, Radjenovic, A, Kozerke, S, Higgins, DM, Sivananthan, MU, Ridgway, JP, Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 52 (2004), 141–146 PubMed PMID: 15236377 10.1002/mrm.20110.
18. Romhilt, DW, Bove, KE, Norris, RJ, Conyers, E, Conradi, S, Rowlands, DT, Scott, RC, A critical appraisal of the electrocardiographic criteria for the diagnosis of left ventricular hypertrophy. Circulation 40 (1969), 185–196 PubMed PMID: 4240354 10.1161/01.CIR.40.2.185.
19. Leitman, M, Lysyansky, P, Sidenko, S, Shir, V, Peleg, E, Binenbaum, M, Kaluski, E, Krakover, R, Vered, Z, Two-dimensional strain–a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am SocEchocardiogr 10 (2004), 1021–1029 10.1016/j.echo.2004.06.019.
20. Piechnik, SK, Ferreira, VM, Lewandowski, AJ, Ntusi, NA, Banerjee, R, Holloway, C, Hofman, MB, Sado, DM, Maestrini, V, White, SK, Merzaka, L, Theodoros, K, Moon, JC, Stefan, N, Paul, L, Robson, MD, Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI. J Cardiovasc Magn Reson, 15(1), 2013, 13 PubMed PMID: 23331520, PMCID 3610210 10.1186/1532-429X-15-13.
21. Kellman, P, S Hansen, M, T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn Reson, 4(16(1)), 2014, 2 10.1186/1532-429X-16-2.
22. Weidemann, F, Niemann, M, Breunig, F, Hermann, S, Beer, M, Stork, S, Voelker, W, Ertl, G, Ertl, G, Wanner, C, Strotmann, J, Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment. Circulation 119:4 (2009), 524–529 PubMed PMID: 19153271 10.1161/CIRCULATIONAHA.108.794529.
23. Fontana, M, White, SK, Banypersad, SM, Sado, DM, Viviana, M, Flett, AS, Piechnik, SK, Stefan, N, Neil, R, Moon, JC, Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR. J Cardiovasc Magn Reson, 14, 2012, 88 PubMed PMID: 23272651, PMCID 3552758 10.1186/1532-429X-14-88.
24. Roujol, S, Weingartner, S, Foppa, M, Chow, K, Kawaji, K, Ngo, LH, Kellman, P, Manning, WJ, Thompson, RB, Nezafat, R, Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE. Radiology, 4, 2014, 140296 Epub ahead of print.
25. Weidemann, F, Breunig, F, Beer, M, Sandstede, J, Turschner, O, Voelker, W, Ertl, G, Knoll, A, Wanner, C, Strotmann, JM, Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain-rate imaging study. Circulation 108 (2003), 1299–1301 PubMed PMID: 12952834 10.1161/01.CIR.0000091253.71282.04.
26. Serri, K, Reant, P, Lafitte, M, Berhouet, M, Le Bouffos, V, Roudaut, R, Lafitte, S, Global and regional myocardial function quantification by Two-dimensional strain: application in hypertrophic cardiomyopathy. J Am Coll Cardiol 47:6 (2006), 1175–1181 PubMed PMID: 16545649 10.1016/j.jacc.2005.10.061.
27. Fontana, A, Zambon, A, Cesana, F, Giannattasio, C, Trocino, G, Tissue doppler, Triplane echocardiography, and speckle tracking echocardiography: different ways of measuring longitudinal myocardial velocity and deformation parameters. A comparative clinical study. Echocardiography 29 (2012), 428–437 PubMed PMID: 22329662 10.1111/j.1540-8175.2011.01618.x.
28. Shanks, M, B Thompson, R, D Paterson, I, Putko, B, Khan, A, Chan, A, Becher, H, Oudit, GY, Systolic and diastolic function assessment in fabry disease patients using speckle-tracking imaging and comparison with conventional echocardiographic measurements. J Am Soc Echocardiography 26 (2013), 1407–1414 10.1016/j.echo.2013.09.005.
29. 1measurements in the human myocardium: the effects of magnetization transfer on the SASHA and MOLLI sequences. Magn Reson Med 70 (2013), 664–670 PubMed PMID: 23857710 10.1002/mrm.24867.